BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7836867)

  • 1. Prevention of ocular inflammation induced by lens protein, endotoxin, and interleukin-1 with synthetic interleukin-1 blockers.
    Chiou GC; Yao QS; Okawara T
    J Ocul Pharmacol; 1994; 10(3):577-86. PubMed ID: 7836867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents.
    Chiou GC; Yao QS; Chang MS; Okawara T
    J Ocul Pharmacol; 1994; 10(1):335-47. PubMed ID: 8207338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of interleukin-1 (IL-1)-induced uveitis with synthetic IL-1 blockers.
    Chiou GC; Chen Z; Xuan B; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1997 Oct; 13(5):427-33. PubMed ID: 9326724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antagonism of interleukin-1 alpha by synthetic interleukin-1 blockers.
    Xiao JG; Schwade N; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(3):369-78. PubMed ID: 8590269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interleukin-1 blockers on ophthalmic wound healing in a rabbit model of trabeculectomy.
    Schwade ND; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(2):125-34. PubMed ID: 8564633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of interleukin-1 blockers on corneal fibroblast proliferation.
    Chen Z; Liu SX; Chiou GC
    J Ocul Pharmacol Ther; 1996; 12(2):169-82. PubMed ID: 8773933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammation and antifibroblastic actions of interleukin-1 blockers.
    Chiou GC; Xuan B; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):375-88. PubMed ID: 9715441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of experimental uveitis with interleukin-1 blockers, CK 123 and CK 124.
    Xuan B; Chiou GC; Chen Z; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1998 Feb; 14(1):31-44. PubMed ID: 9493781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats.
    Xiao JG; Chiou GC
    J Ocul Pharmacol Ther; 1996; 12(3):323-9. PubMed ID: 8875338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic anti-inflammation by synthetic interleukin-1 blockers.
    Chiou GC; Liu SX
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):405-8. PubMed ID: 10678085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of crystallins-induced inflammation in rabbit eyes with five phytogenic compounds.
    Yao QS; Chiou GC
    Zhongguo Yao Li Xue Bao; 1993 Jan; 14(1):13-7. PubMed ID: 8503279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ocular inflammation by chalcone derivatives and prednisolone.
    Chiou GC; Yao QS; Varma RS
    J Ocul Pharmacol; 1992; 8(3):213-23. PubMed ID: 1453084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiuveitis and inhibition of fibroblast-like corneal and conjunctival cell cultures by interleukin-1 blockers, CK 125, CK 126 and CK 128.
    Xuan B; Chiou GC; Yamasaki T; Okawara T
    Ophthalmic Res; 1998; 30(3):180-8. PubMed ID: 9618722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of interleukin-1alpha-induced uveitis and inhibition of fibroblast-like cell proliferation by synthetic interleukin-1 blockers.
    Chiou GC; Zhou YH; Xuan B; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1999 Aug; 15(4):351-62. PubMed ID: 10463874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interleukin-1 blockers, CK112, and CK116 on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro.
    Zou Y; Xu X; Chiou GC
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):19-25. PubMed ID: 16503771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-1-induced uveitis and corneal fibroblast proliferation by interleukin-1 blockers.
    Chiou GC; Xuan B; Liu Q; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 2000 Oct; 16(5):407-18. PubMed ID: 11110032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of trabeculectomy to study the pharmacological modulation of ophthalmic wound healing.
    Schwade ND; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(2):113-23. PubMed ID: 8564632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of lens protein-induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors.
    Chang MS; Chiou GC
    J Ocul Pharmacol; 1989; 5(4):353-60. PubMed ID: 2516867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of synthetic interleukin-1 blockers on uveitis in rats].
    Zhou Y; Li Z; An W; Chiou G
    Zhonghua Yan Ke Za Zhi; 2000 Jan; 36(1):62-4. PubMed ID: 11853587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of 3H-pyridazino[4,5-b][1,4]benzothiazin-4(10H)-one derivatives.
    Vittorio F; Pappalardo MS; Ronsisvalle G; Caruso A; Cutuli VM; Amico-Roxas M
    Farmaco; 1994 Apr; 49(4):237-44. PubMed ID: 8049003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.